Analyst Expectations For Corteva's Future
Portfolio Pulse from Benzinga Insights
Analysts have recently adjusted their ratings and price targets for Corteva (NYSE:CTVA), showing a negative shift in sentiment. The average 12-month price target is now $59.92, down 13.37% from previous estimates. Multiple analysts from firms such as UBS, Berenberg, and Morgan Stanley have lowered their price targets, reflecting changes in market conditions and company performance. Corteva's financial indicators show a decline in revenue growth, below-average net margin and ROE, and a conservative debt management approach. The company, a leader in seed and crop chemicals, was spun off from DowDuPont in 2019.
January 11, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have lowered their price targets for Corteva, indicating a bearish outlook. The company's financials show a revenue decline and below-average profitability metrics, which may concern investors.
The unanimous lowering of price targets by analysts from reputable firms suggests a strong consensus on Corteva's underperformance. This negative sentiment, combined with the reported financial challenges, is likely to put downward pressure on CTVA's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100